Blog

Oxford Nanopore Technologies has announced the appointment of Francis Van Parys as its next Chief Executive Officer, effective March 2, 2026

QIAGEN has announced its plans to acquire Parse Biosciences, a rapidly growing company known for its instrument-free single-cell technology.

The ASHG is currently hosting its 2025 Annual Meeting in Boston, the event brings together thousands of scientists, clinicians, and innovators from around the world.

PacBio and EpiCypher announced a strategic alliance within the PacBio Compatible program that incorporates EpiCypher's CUTANA® Hia5 enzyme into PacBio's Fiber-seq assays with HiFi sequencing

ArgenTag is democratizing single-cell sequencing using long-read technology. Its single-cell RNA library kit is compatible with long-read sequencing platforms such as Oxford Nanopore and PacBio.

Thaysen assures that Illumina will achieve solid growth by 2027, driven by its commitment to multiomics and a strategy tailored to researchers.

Clareo Biosciences has partnered with Pacific Biosciences, to leverage the power of long-read sequencing together with Clareo's applied expertise to identify immune signatures and design predictive algorithms to aid in patient diagnosis and stratification.

BioSkryb Genomics has obtained an exclusive license to a patent that enables combined DNA methylation and genomic variant analysis in a single cell

The Palo Alto, California-based company, now valued at $120 million, has developed a scalable way to quickly generate crucial biological data needed for AI models–and use them to find new cures for cancer.

Gordon is stepping down as CEO of Oxford Nanopore and is set to leave the post before the end of 2026.

10x Genomics is acquiring Scale Biosciences in a $30M cash-and-stock deal plus milestones.

The Arc Institute recently launched the Virtual Cell Atlas, a resource of over 300 million cells, and is now partnering with 10x Genomics and Ultima Genomics to make single-cell data collection faster, more scalable, and more affordable, accelerating research aimed at improving human health.

Sanger and PacBio will apply long read scRNA sequencing to identify RNA isoforms, using PacBio’s HiFi long-read technology to provide high-resolution maps.

CZI, in collaboration with partners including 10x Genomics, Ultima Genomics, and a group of leading researchers launched the Billion Cells Project, an effort to generate an unprecedented one billion cell dataset to fuel rapid progress in AI model development in biology.